Ventyx Biosciences Inc (VTYX) PT Raised to $63 at Credit Suisse
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts VTYX Hot Sheet
Price: $14.00 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 16
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 17 | New: 16
Join SI Premium – FREE
Credit Suisse analyst Tiago Fauth raised the price target on Ventyx Biosciences Inc (NASDAQ: VTYX) to $63.00 (from $53.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Principal Financial Group (PFG) PT Lowered to $112 at UBS
- JPMorgan Upgrades Unilever Indonesia Tbk (UNVR:IJ) (UNLRF) to Neutral
- Nantong Jianghai Capacitor (002484:CH) PT Raised to RMB42 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
